Bismuth-based quadruple therapy

DRUG3 trials

Sponsors

National Cheng-Kung University Hospital, University of Latvia, University of Health Sciences Lahore

Conditions

Comorbidities and Coexisting ConditionsGastric CancerH Pylori EradicationH Pylori InfectionH-pyloriHELICOBACTER PYLORI INFECTIONSHelicobacter Pylori InfectionMedication Adherence

Unknown Phase

Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity

CompletedNCT05475431

National Cheng-Kung University HospitalComorbidities and Coexisting Conditions, Helicobacter Pylori Infection, Medication Adherence +3

Start: 2020-05-06End: 2023-12-31Updated: 2024-11-07

H. Pylori Screen-and-treat Study in a Population of Young Adults

RecruitingNCT06275204

University of LatviaGastric Cancer, H-pylori, H Pylori Eradication +1

Start: 2024-03-04End: 2026-12-01Target: 6800Updated: 2024-03-05

Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Not yet recruitingNCT07574983

University of Health Sciences LahoreHELICOBACTER PYLORI INFECTIONS

Start: 2026-06-01End: 2026-12-30Target: 90Updated: 2026-05-08